Syngene International Ltd is a leading pharmaceutical company based in India, specializing in contract research and manufacturing services. With a low ESG risk rating score of 12.4, the company is dedicated to promoting sustainability and good governance practices. Syngene's services range from Oligonucleotide synthesis to clinical development and commercial supplies, catering to clients in the US and beyond. Operating in various countries, Syngene generates revenue through its high-quality research and manufacturing solutions.